Contemporary Management of Stable Coronary Artery Disease

Dario Tino Bertolone1,2, Emanuele Gallinoro1,3, Giuseppe Esposito1,2

  • 1Cardiovascular Center Aalst, OLV-Clinic, Aalst, Belgium.

Insights

Assessing pre-test probability (PTP) improves coronary artery disease (CAD) diagnosis, guiding appropriate non-invasive testing like coronary computed tomography angiography (CCTA). This approach optimizes management for chronic coronary syndromes (CCS) and reduces unnecessary invasive procedures.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Preventive Medicine

Background:

  • Coronary artery disease (CAD) is a primary cause of death globally.
  • Accurate pre-test probability (PTP) assessment aids in selecting appropriate diagnostic tests for suspected CAD.
  • Non-invasive imaging, particularly coronary computed tomography angiography (CCTA), is crucial for initial evaluation.

Purpose of the Study:

  • To present an updated diagnostic and therapeutic strategy for stable coronary artery disease (CAD).
  • To emphasize the role of PTP and non-invasive imaging in guiding CAD management.
  • To discuss current approaches for chronic coronary syndromes (CCS) and secondary prevention.

Main Methods:

  • Review of current literature on CAD diagnosis and management.
  • Emphasis on pre-test probability (PTP) assessment using patient characteristics, gender, and symptoms.
  • Discussion of non-invasive imaging (CCTA) and invasive coronary angiography (ICA) roles.
  • Inclusion of physiology and imaging-guided revascularization strategies.
  • Overview of contemporary medical therapies for secondary prevention.

Main Results:

  • PTP assessment refines the selection of diagnostic tests, improving accuracy.
  • Coronary computed tomography angiography (CCTA) serves as a first-line non-invasive tool for suspected CAD.
  • Invasive coronary angiography (ICA) is reserved for inconclusive non-invasive tests or high clinical likelihood.
  • A significant percentage of patients undergoing ICA have non-obstructive coronary artery disease (INOCA).
  • Physiology and imaging-guided revascularization are key for managing chronic coronary syndromes (CCS).

Conclusions:

  • An integrated approach using PTP, non-invasive imaging (CCTA), and physiology-guided revascularization enhances CAD management.
  • This strategy aims to improve patient outcomes and reduce unnecessary invasive procedures.
  • Optimal medical therapy is essential for secondary prevention in CAD patients.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
40
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
57
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
154
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
79